RhAPPcast

RhAPPcast

Por: Rheumatology Advanced Practice Providers (RhAPP)
This is the official podcast of Rheumatology Advanced Practice Providers (RhAPP), a non-profit 501c3 organization dedicated to developing educational programs, providing professional advancement services, and assembling resources for—and guided by—advanced practice providers (APPs). 
 
Through our peer-to-peer network, we seek to support the integral role APPs play in the rheumatology healthcare community by providing the most relevant and timely information and communication for the treatment of their patients with rheumatic diseases. 
138 episodios disponibles

Latest episodes of the podcast RhAPPcast

Mostrando página 4 de 7

FAQ: What Are CNIs? Treating Lupus Nephritis with the Latest ACR Guidelines 01/04/2025
RhAPPcast: Elevating Care in LN: What the New ACR Guidelines Mean for Patients & How APPs can Apply Them 27/03/2025
FAQ: How do IL-23 and IL-17 Inhibitors Differ in Clinical Efficacy 25/03/2025
Journal Club Review: Ixekizumab vs. Guselkumab in Plaque Psoriasis (12-Week Trial Results) 19/03/2025
Medication Review: What is Voclosporin and How Does it Work? 14/03/2025
FAQ: According to the New 2024 ACR Guidelines for LN, What Are the Treatment Goals For Patients With LN? 13/03/2025
Journal Club Review: Long-Term Safety of Guselkumab in Patients with Psoriatic Disease 12/03/2025
RhAPPcast: Navigating Leflunomide Use in Pregnant Patients with Sjögren’s Syndrome 04/03/2025
FAQ: According to the New 2024 ACR Guidelines, How Do You Treat LN? 28/02/2025
FAQ: How Do You Interpret cDAPSA/DAPSA and MDA? 26/02/2025
FAQ: How Do You Explain The Timing of Ixekizumab's Clinical Efficacy to Patients? 19/02/2025
FAQ: 2024 ACR Guidelines: Screening & Diagnosing Lupus Nephritis in SLE Patients 14/02/2025
RhAPPcast: LN Updates Unpacked: Insights on New ACR Guidelines 11/02/2025
FAQ: How is Lupus Nephritis Defined? 07/02/2025
FAQ: How Does Real-World Evidence Differ From Randomized Controlled Trials 05/02/2025
FAQ: How Long Has It Been Since the Last ACR LN Guideline Updates, and Why Is This Significant? 31/01/2025
Journal Club Review: Effectiveness of Methotrexate and Leflunomide as Corticoid-Sparing Drugs 28/01/2025
RhAPPcast :The Clinical Utility of Guselkumab in Axial PsA 22/01/2025
Journal Club Review: Efficacy & Safety of Ixekizumab ± Methotrexate in PsA (52-Week SPIRIT-H2H) 15/01/2025
FAQ: How Do You Interpret Radiographic Progression Using Modified-vdHS or mTSS? 08/01/2025
« Primera ‹ Anterior 1 2 3 4 5 6 7 Siguiente › Última »
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA